Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 430,200 | 642,600 | 241,000 | 358,300 | 436,000 |
| Receivables | 155,900 | 159,200 | 191,300 | 175,000 | 181,800 |
| Inventories | 367,900 | 350,700 | 546,300 | 425,500 | 400,700 |
| Other current assets | 225,600 | 0 | 0 | 0 | 0 |
| TOTAL | $1,221,300 | $1,210,400 | $1,118,500 | $1,084,200 | $1,100,300 |
| Non-Current Assets | |||||
| PPE Net | 716,800 | 817,600 | 806,700 | 798,400 | 807,500 |
| Intangibles | 827,100 | 947,000 | 947,600 | 801,500 | 815,500 |
| Other Non-Current Assets | 184,600 | 191,300 | 35,700 | 51,300 | 57,100 |
| TOTAL | $1,728,500 | $1,955,900 | $1,790,000 | $1,651,200 | $1,680,100 |
| Total Assets | $2,949,800 | $3,166,300 | $2,908,500 | $2,735,400 | $2,780,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 950,700 | 957,300 | N/A | 31,600 | 31,600 |
| Accounts payable and accrued liabilities | 124,200 | 103,500 | 103,800 | 106,200 | 107,300 |
| Accrued Expenses | 78,100 | 122,200 | 118,400 | 114,700 | 85,700 |
| Other current liabilities | 25,200 | 45,900 | 46,200 | 24,200 | 24,600 |
| TOTAL | $1,215,700 | $1,228,900 | $268,400 | $276,700 | $249,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 447,700 | 448,500 | 1,032,100 | 793,600 | 801,500 |
| Other Non-Current Liabilities | 24,100 | 41,500 | 44,900 | 58,500 | 59,600 |
| TOTAL | $531,500 | $549,700 | $1,190,800 | $945,500 | $955,900 |
| Total Liabilities | $1,747,200 | $1,778,600 | $1,459,200 | $1,222,200 | $1,205,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,448 | 50,140 | 49,888 | 49,862 | 50,244 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 551,000 | 738,700 | 822,000 | 897,700 | 954,100 |
| Other shareholders' equity | 1,300 | 3,400 | -4,900 | -5,800 | -9,700 |
| TOTAL | $1,202,600 | $1,387,700 | $1,449,300 | $1,513,200 | $1,575,300 |
| Total Liabilities And Equity | $2,949,800 | $3,166,300 | $2,908,500 | $2,735,400 | $2,780,400 |